CRM
57
7
ACN
56
-3
AAP
36
-5
ADSK
66
10
CAG
34
-3
CF
48
3
D
43
-2
EFX
47
4
AAL
50
-4
AIZ
52
2
CCI
36
2
A
48
-3
DUK
55
-2
CMCSA
42
-2
AES
57
13
AMP
69
3
ALLE
39
-5
AVGO
26
-2
AMGN
36
-3
EL
52
-10
CRM
57
7
ACN
56
-3
AAP
36
-5
ADSK
66
10
CAG
34
-3
CF
48
3
D
43
-2
EFX
47
4
AAL
50
-4
AIZ
52
2
CCI
36
2
A
48
-3
DUK
55
-2
CMCSA
42
-2
AES
57
13
AMP
69
3
ALLE
39
-5
AVGO
26
-2
AMGN
36
-3
EL
52
-10
Financhill
Back

Humacyte, Inc. Stock Price Chart

This AI Layer Just Raised Its Share Price

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
25

HUMA
Humacyte, Inc.

Last Price:
$1.30
Seasonality Move:
-22.55%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Powerhouse Raises Price - But Room Remains

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HUMA is experiencing slight buying pressure.

Humacyte, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.3 Sell
20-day SMA: 1.26 Buy
50-day SMA: 1.54 Sell
200-day SMA: 1.99 Sell
8-day EMA: 1.29 Buy
20-day EMA: 1.32 Sell
50-day EMA: 1.47 Sell
200-day EMA: 2.22 Sell

Humacyte, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 45.74 Sell
Chaikin Money Flow: 440696 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.18 - 1.46) Sell
Bollinger Bands (100): (1.33 - 2.11) Sell

Humacyte, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Humacyte, Inc. Stock

Is Humacyte, Inc. Stock a Buy?

  • Humacyte, Inc. share price is 1.30 while HUMA 8-day simple moving average is 1.30, which is a Sell signal.
  • The stock price of HUMA is 1.30 while Humacyte, Inc. 20-day SMA is 1.26, which makes it a Buy.
  • Humacyte, Inc. 50-day simple moving average is 1.54 while HUMA share price is 1.30, making it a Sell technically.
  • HUMA stock price is 1.30 and Humacyte, Inc. 200-day simple moving average is 1.99, creating a Sell signal.

HUMA Technical Analysis vs Fundamental Analysis

Sell
25
Humacyte, Inc. (HUMA) is a Sell

Is Humacyte, Inc. a Buy or a Sell?

  • Humacyte, Inc. stock is rated a Sell
    The current Humacyte, Inc. [HUMA] share price is $1.30. The Score for HUMA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.

Humacyte, Inc. Stock Info

Market Cap:
243.5M
Price in USD:
1.30
Share Volume:
3.1M

Humacyte, Inc. 52-Week Range

52-Week High:
6.77
52-Week Low:
1.09
Sell
25
Humacyte, Inc. (HUMA) is a Sell

Humacyte, Inc. Share Price Forecast

  • What is the Humacyte, Inc. stock price today?
    The Humacyte, Inc. stock price is 1.30 USD today.
  • Will HUMA stock go up or go down?
    Humacyte, Inc.> share price is forecast to RISE/FALL based on technical indicators
  • Is Humacyte, Inc. overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Humacyte, Inc. is overvalued.

Is Humacyte, Inc. Stock a Buy?

  • Humacyte, Inc. share price is 1.30 while HUMA 8-day exponential moving average is 1.29, which is a Buy signal.
  • The stock price of HUMA is 1.30 while Humacyte, Inc. 20-day EMA is 1.32, which makes it a Sell.
  • Humacyte, Inc. 50-day exponential moving average is 1.47 while HUMA share price is 1.30, making it a Sell technically.
  • HUMA stock price is 1.30 and Humacyte, Inc. 200-day simple moving average is 2.22, creating a Sell signal.

Fundamental Analysis of Humacyte, Inc.

Is Humacyte, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and a decrease next year of $0.15 per share.

Technical Analysis of Humacyte, Inc.

Should I short Humacyte, Inc. stock?

* Humacyte, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.